Hyperproinsulinemia is a characteristic feature of non-insulindependent diabetes mellitus (NIDDM) c a d by panaeatic b-cell dysfunction through a secretion-related alteration or impaued proinsulin proassing. We have investigated the insulin pmcusing and seaetion inffvnmomysobesusfed with low-and high-energy diets, which represent a model for dietinduced NIDDM. With a high-energy diet the animals develop hyperglycemia and hyperinsulinemia, whereas those maintained on a low-energy diet remain normoglyamic. Although a large amount of insulin immunoreactivity was detected in b-cells of the normoglycemic compared to hyperglycemic animals, in situ hybridization for insulin mRNA demonstrated a particularly high signal in the b-cells of the hyperglycemic animals. By electron miaoscopy, the b-cells of normoglpmic animals displayed large accumulations of secretory granules, whereas those of the hyperglycemic animals contained very few granules and large deposits of glycogen. These results d e c t a seaetory resting condition for the cells of the normoglycemic animals in contrast to stimulated synthetic and secretory activities in the cells of the hyperglycemic ones. Using colloidal gold immunocytochemistry at the electron miaoscopic level, we have exam-
Introduction
Non-insulin-dependent diabetes mellitus (NIDDM) is characterized by a pancreatic b-cell dysfunction reflected by increased secretion of proinsulin (1) (2) (3) (4) (5) (6) (7) . However, the exact causes of hyperproinsulinemia are still hypothetical. ined subcellular proinsulin ptocessing in relation to the convertases PC1 and PC2. Immunolabeling of proinsulin, insulin, C-peptide, PC1, and PC2 in different cell compartments involved in b-cell secretion were evaluated. Both PC1 and PC2 antigenic sites were detected in b-cells of hyperglycemicPSammomys, but their labeling intensity was weak compared to the cells of normoglycemic animals. In both groups of animals, higher levels of PC2 were found in the Golgi apparatus than in the immature granules. Major deaeases in proinsulin, insulin, PC1, and PC2 immunoreactivity were recorded in p-cells of the hyperglycemic Psammomys. In addition, all these antigenic sites were detected in lysosome-like structures, revealing a major degradation process. These results suggest that the insulin-secreting cells in hyperglycemic Psammomys o k are in a chronic smetory state during which impaued processing of proinsulin appears to take place. ()Hisrochem Cyrochem 43771-784, and endocrine-specific prohormone convertases PC1 and PC2 (10) (11) (12) (13) (14) (15) (16) . Proinsulin conversion yields equimolar amounts of insulin and C-peptide. Whereas insulin is able to crystallize in granules, forming the characteristic electron-dense core, C-peptide remains soluble in the granule periphery (17, 18) . This process is extremely efTicient in normal subjects, in which >95% of secreted insulin-like material consists of mature insulin (18) . In addition, essentially no proinsulin spills over to the nonregulated constitutive pathway (19) . Under hyperglycemic circumstances, however, the proportions of circulating proinsulin rise from less than the normal 10% to more than 40% (20, 21) .
Recent advances in understanding of the proinsulin processing mechanisms and new experimental tools have provided several avenues for characterizing the mechanism(s) of the B-cell dysfunction that may be responsible for the observed hyperproinsulinemia. Some of these possibilities could include a secretion-related mechanism involving either a defective glucose-regulated insulin release mechanism or an increased secretory demand from the B-cell. Alternatively, a defect in the processing machinery could be the culprit. This may involve (a) synthesis of genetic variants of the prohormone convertases, (b) defective regulation of glucose-induced PC1 biosynthesis, (c) a disproportionate ratio between PC1 and PC2, (d) defective processing of proPC1 andlor proPC2 to the enzymatically active PC1 and PC2, (e) an adverse change in the inner environment of the B-granules, or (f) mistargeting of the convertases andlor of the prohormones away from the granules (1).
The present study was conducted in an attempt to better understand possible relationships between intracellular insulin biosynthesis, processing, storage, release, and degradation under normal and hyperglycemic conditions in the Psammomys obesus (sand rat) model of diet-induced NIDDM. When maintained under laboratory conditions on ad libitum rodent diet, these desert animals develop obesity and hyperinsulinemia with or without hyperglycemia, a syndrome that is, in some respects, comparable to NIDDM in humans (22-30). Through control of the diet, it is possible to identlfy several stages in the development of glucose intolerance, allowing determination of the sequence of events that lead to the induction of diabetes. When the animals are maintained on a suitable dietary regimen, the Psammomys model provides an opportunity to study adaptive changes in @-cell insulin secretion before the manifestation of hyperglycemia (31.32).
Using cytochemical techniques at the light and electron microscopic levels, in the present study we investigated subcellular insulin processing within the Psammomys pancreatic @-cells with regard to convertases PC1 and PC2, proinsulin, insulin, and C-peptide immunolabeling .
Materials and Methods
Animals. Psmnmomys obesus of the diabetic line were obtained from a colony established by Professor J.H. Adler at the Animal Farm of the Hebrew University-Hadassah Medical School (Jerusalem. Israel). The animals were fed a low-energy (LE) 2.38 kcallg or a high-energy (HE) 2.93 kcal/g diet. Details of food composition, breeding, and maintenance have been well characterized and previously reported (33-36).
Blood glucose and plasma insulin levels were determined by the glucose oxidase and the radioimmunoassay (Medgenix; Olen, Belgium) methods, respectively. Animals were divided into two groups according to their metabolic status. After weaning, one group of animals was kept for 2 weeks on the LE diet and had consistent normoglycemia and normoinsulinemia. The other group was kept on the HE diet and developed both hyperinsulinemia and hyperglycemia. Over the 2-week period, all animals consumed similar amounts of food (125 glday) irrespective of their diet.
Weight gains were 59.7 g/2 weeks for the animals on the HE diet and 46.2 g12 weeks for those on the LE diet. All of the animals were sacrificed in the fed state.
Tissue Samples. Pancreatic tissue from 14 animals of both groups was fmed by immersion with 1% glutaraldehyde in 0.1 mollliter phosphate b&r (pH 7.4) for 2 hr at room temperature (RT), dehydrated in graded methanol, and embedded in Unicryl (British BioCell; CardifT, UK) at -2O'C (37.38). In addition, post-fixation in osmium and Epon embedding were also carried out. Semi-thin sections were cut and processed for light microscopic immunohistochemistry. Thin sections mounted on nickel grids were processed for post-embedding colloidal gold immunocytochemistry (39). Bouin's-fixed tissues were processed for embedding in paraffin and 5-pm thick sections were made for in situ hybridization (40) .
Antibodies. Several rabbit polyclonal antibodies raised against the prohormone convertases PC1 and PC2 and the C-peptide, a guinea pig antiinsulin antibody, and an anti-proinsulin monoclonal antibody (MAb) were used to reveal the corresponding antigens. For PC1, two antibodies were employed: (a) the Ab C-mPC1 directed against the carboxyl terminal (C-terminal) segment 629-726 of mouse PC1 (mPC1) and (b) the Ab N-mPC1 directed against the amino terminal (N-terminal) segment 84-98 +Tyr of mouse PC1 (41, 42) . The N-terminal-directed antibody recognizes the 87, 84, and 66 KD forms ofPC1. whereas the C-terminal directed antibody recognizes only the 87 KD proPC1 and 84 KD form of PC1 (42.43) .
For the labeling procedure a mixture of both antibodies was applied. For PC2, fwo C-terminal-directed antibodies were used, the Ab C-mPC2 directed against the carboxyl t e d segment 529-537 of mouse PC2 (mPC2) (42.44) and the Ab C KLH-mPC2 directed against the last 10 amino acids of the C-terminal tail of PC2 (kindly provided by Dr. R.H. Angeletti, Albert Einstein College of Medicine, New York). The specificity of these antibodies was previously demonstrated by immunochemical and immunocytochemical techniques (38.41.42.4446 ). The guinea pig anti-insulin antibody (Miles Biochemicals; Elkhart, IN) and the rabbit anti-synthetic C-peptide antibody (ImmunoNuclear; Stillwater, MN) were both previously characterized and their specificity assessed through immunogold methods (17) . The human proinsulin-specific MAb (Novo Nordisk BioLabs; Bagsraerd, Denmark), was previously chvlcnrizcd (47) and uossmcdvity with the rat proinsulin was established (48) . It was shown to recognize an epitopc at the B-C chain junction at the dibasic processing site ( A f g h g ) in position 31-32 of human proinsulin. In this respect, it is important to note that the C-peptide antiserum recognizes both the C-peptide region of proinsulin and the C-peptide molecule itself released by cleavage of proinsulin. Likewise, the anti-insulin antiserum reacts primarily with insulin but exhibits a certain degree of crossreactivity with proinsulin.
Histochemistry. For immunohistochemistry, semi-thin sections of Unicryl-embedded pancreas were cut and incubated overnight at 4'C with the anti-insulin antibody diluted 1:50. To reveal the immunostaining. the protein A-gold method followed by silver enhancement was performed (49) . The sections were incubated with a protein A-gold complex prepared with 15-nm gold particles, as previously described (50) . for 60 min at RT and the silver enhancement was carried out for 7 min at RT using the IntenSE kit (Janssen Life Science; Beerse, Belgium).
For demonstration of insulin mRNA, in situ hybridization was carried out on sections of paraffin-embedded tissue (40.51). Deparaffinized and rehydrated tissue sections were processed through 2 x SSC for 10 min at 60'C, 0.05 M Xis, pH 7.6, for 5 min, and treated with proteinase K (15 pg/ ml in %is buffer) for 60 min at 37'C. Sections were fixed with 0.4% pardormaldehyde for 20 min at 4°C. The sections were pre-hybridized for 60 min . BEN-SASSON, KALMAN, BAR-ON, C&TIEN, SEIDAH . . at 37'C with the pre-hybridization buffer (0.6 M NaCI, 30% formamide. 150 pglml salmon sperm DNA). Hybridization was carried out overnight at 37'C with the rat insulin probe cocktail tagged with digoxigenin at the 5' end (British Biotechnology; Oxon. UK) at 200 nglml in the prehybridization buffer. The sections were washed with SSC in decreasing concentrations for a total of 30 min. The sections were then processed for immunolabeling of the digoxigenin using an alkaline phosphatase-tagged antidigoxigenin (1:SOO) for 60 min at RT, followed by incubation with nitroblue tetrazolium (NBT) and 5-bromo-4-chloro-3-indolyl-phosphate (BCIP) detection kit (Boehringer Mannhcim; Laval, Quebec. Canada) (51).
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Immunoelmron Microscopy. For the immunolabeling, thin sections of glutaraldehyde-fixed, Unicryl-embedded tissues were first transferred for 30 min to a drop of 0.15 mol/liter PBS, pH 7.2. containing 1% ovalbumin and then incubated with the specific antibody brought to the appropriate dilution: the Ab C-mPCI (1:lSO) + Ab N-mPCI (1:lOO) overnight at 4'C the Ab C-mPC2 (1:500); the monoclonal anti-proinsulin (1:IO). overnight at 4°C; the anti-insulin (1:200) 4 hr at RT; and the anti-C-peptide (1:50) 4 hr at RT. The sections were further rinsed with PBS to remove unbound immunoglobulins and then incubated for 30 min at RT with either protein A-gold or protein AG-gold complexes prepared with IO-nm gold particles (OD120 0.5) (52.53). The grids were then washed with PBS and distilled water, dried, and stained with uranyl acetate before examination.
Control experiments in which the antibodies to PCI, PC2, insulin. and the C-peptide were adsorbed with an excess of their corresponding antigens [mPCI, mPC2, porcine insulin (Miles), or synthetic human C-peptide (Calbiochem; La Jolla. CA)] before the labeling protocol were previously reported (17, 38) . Other controls were performed by incubating the tissue sections with a non-related rabbit antiserum instead of the specific one or directly with protein A-gold without prior exposure to any antibody.
Immunogold Quantification. Quantitative evaluations ofthe labeling present over the E R , Golgi area, and immature and matun secretory granules were carried out according to previously described protocols (17) . Gold particles present over nucleus and mitochondria were also evaluated 1s a reflection of background staining. Labeling intensities are reported without subtracting the above-mentioned background values. Micrographs of at least five different pancreatic p-cells from each animal were recorded and enlarged to a final magnification of ~40,000. The area of cell compartments of interest for the present investigation was evaluated by direct planimetry using the Videoplan-2 system (Carl Zeiss; Don Mills, Ontario. Canada). The number of gold particles present in those areas was directly counted and the density of labeling was expressed as the number of gold particles/pm2. In addition, stereological evaluation of the secretory granules was performed by measuring their diameter and surface. The number of granule^/^^ of cell cytoplasm was determined in both groups of animals. Values generated from the micrographs of all animals were pooled. averaged, and statistically evaluated. Because not all the micrographs displayed all the cell compartments, we tried to collect at least 18 
Results

Metabolic Measurements
By using two diets differing in their energy load, high energy vs low energy, it was possible to generate diabetic animals. In the diabetic line, hyperglycemia and hyperinsulinemia developed together in each individual animal. Their plasma glucose and insulin-like immunoreactivity levels were 351.28 2 5.18 mgldl and 264.28 2 4.10 pUlml, respectively. In addition, these animals demonstrated hypercholesterolemia, hypertriglyceridemia. increased body weight, and increased fat tissue, as reported previously (36) . Most of these metabolic abnormalities are exhibited by this line 7-14 days after being transferred to the HE diet, particularly in the fed state. Both diabetes and obesity were prevented in the animals of this diabetic line by feeding them an LE diet. Under this condition, their glucose and insulin levels were within the normal range: 82.42 f 2.10 mgldl and 35.28 2 1.80 pUlml, respectively.
Light and ELectron Microscopic Cytochemistry
By light microscopy, insulin immunostaining of the islets of normoglycemic Psammomys was intense, whereas that of the hyperglycemic ones was quite weak (Figures la and 1b) . Conversely, with in situ hybridization for insulin mRNA, the signal obtained on islet cells of the normoglycemic Psammomys was at background level, whereas that of the hyperglycemic ones was quite strong (Figures IC and Id) .
By electron microscopy, the pancreatic p-cells of the normoglycemic animals displayed a normal appearance, with no glycogen accumulation (Figure 2a ). They were often heavily granulated, with a mixed population of dark-and light-cored granules. Some cells were loaded with granules, particularly the large pale ones delineated by a smooth membrane. The RER and the Golgi apparatus were well developed. In contrast, the p-cells of the hyperglycemic Psammomys were degranulated. with vacuolization of the cytoplasm and infiltration by large glycogen deposits (Figure 2b ). The few secretory granules were of small size, the typical ones with the electron-dense core surrounded by a clear halo being extremely rare. The RER and the Golgi apparatus appeared quite developed.
Results from the morphometric evaluation demonstrated that indeed the diameter of the granules in the normoglycemic animals was 2.5-fold larger than that of the hyperglycemic animals (mean 412 f 2.14 nm vs 167 2 0.93 nm). In addition, there were about 2.5-fold more granules/pZ of cell cytoplasm in the normoglycemic vs the hyperglycemic Psammomys (2.42 -C 0.001 granu l e s / p 2 vs 0.98 ? 0.001 granules/pm2).
Regarding the subcellular localization of proinsulin, insulin, C-peptide, and PC1 and PC2 in 0-cells of normoglycemic animals. specific labeling was found in RER, Golgi area, and secretory granules (Figures 3-7) . I"unogo1d labeling for both peptides and PC1 was distributed Over these compartments, with higher intensity over the secretory granules. PC2, on the other hand, although present along the secretory pathway, displayed a higher intensity in the Golgi apparatus ( Table 1) . The proinsulin immunoreactivity, however, was restricted to very few light-cored granules (Figure 3a and 3b). In fact, in spite oftheir appearance, most of the pale granules exhibited positive labeling for insulin and no reactivity for proinsulin (Figure 4a ).
In the hyperglycemic animals, the morphological distinction between immature and mature granules could not be defined and thus far only one category of granules has been recognized. Labeling for proinsulin, insulin, and C-peptide, as well as for the prohormone convertases PC1 and PC2, was distributed Over the RER, Golgi area, and secretory granules (Figures 3-7) . Labeling for insulin and prohormone convertases was also associated with small cytoplasmic vesicles in the Golgi area (Figures 4b and 4c) . In addition, significant labeling for proinsulin, insulin, C-peptide, and convertases was found over large lysosome-like structures that were not encountered in cells of normoglycemic animals (Figures 3d.  4d, and 5b) .
Control experiments performed at the electron microscopic level have previously demonstrated the specificity of the immunolabeling (17, 38) and have been confirmed here. Indeed, adsorption of each antibody with an excess of its corresponding antigen before incubation resulted in drastic reduction of the labeling.
In normoglycemic animals, quantitative analysis of the relative distribution of the labeling in the different cell compartments revealed a pattem of gradual increase in intensity along the RER-Golgi granule secretory pathway for both peptides and enzymes ( Table  1 ). The peak for proinsulin, insulin, C-peptide, and prohormone convertase PCl was reached over the pale granules, whereas intensity of labeling for PC2 was higher in the Golgi apparatus. In P-cells of the hyperglycemic animals. the results also showed a gradual increase in intensity along the RER-Golgi granule secretory pathway for proinsulin, insulin, C-peptide, and PC1 (Table 2) . However, in these animals the number of proinsulin-rich granules in relation to the total number of granules was at least twice as high as in normoglycemic animals, 32.4% vs 13.7%. As in the case of the normoglycemic animals, PC2 immunoreactivity in the hyperglycemic ones reached a peak of intensity over the Golgi apparatus and then decreased over the granules. Because of major differences in number and surface area occupied by the granules in the B-cells of normo-vs hyperglycemic animals, the overall densities of labeling per unit cytoplasm area differed significantly between the two groups (Table 3) . We have estimated the density of labeling over the cytoplasm in relation to the number of granules/m2 ('Gble 3). Under this evaluation, labeling densities for all antigens were much lower in hyperglycemic than in normoglycemic animals ( Eble 3). We should further point out the very low values obtained for the convertases, particularly for PC2.
Discussion
The Psammomys obesus model exhibits many of the features characteristic of human NIDDM, including development of diabetes dependent on caloric intake and diet-induced obesity. Animals from the diabetic line fed the HE diet go through a phase of transient hyperinsulinemia-normoglycemia and then develop hyperinsulinemia, hyperglycemia, obesity, and diabetes. These result from the imbalance between insulin secretion and insulin sensitivity and involve pancreas, liver, and peripheral tissues (31, 36, 54, 55) .
Regarding the pancreas, in the present study we questioned whether there is a 0-cell defect in the processing and maturation of insulin that might be responsible for the development of diabetes in these animals. Using an immunocytochemical technique at the electron microscopic level, we have previously reported, in normal Sprague-Dawley rat pancreatic p-cells, the co-localization and concentration of proinsulin and of convertases PC1 and PC2 within the same immature secretory granules (38) .
The results of the present study show that Psammomys fed an HE diet and exhibiting hyperglycemia, hyperinsulinemia, and obesity may indeed have defective insulin secretion. Regarding the proinsulin, the results obtained support some abnormalities of endoproteolytic processing. Both PC1 and PC2 antigenic sites were detected in o-cells of these animals, but their labeling density along the secretory pathway was weak. There was an increase from the RER to the Golgi apparatus, followed by a decrease to very low values over the secretory granules. Furthermore, labeling for PC2 reached a peak value over the Golgi apparatus instead of over the granules, as found in normal Sprague-Dawley rats (38) . even in the normoglycemic Psammomys. In addition, in the hyperglycemic animals very few granules were present in the cytoplasm, and insulin immunoreactivity was detected in lysosome-like structures. These observations may rdlect impaired processing. Evidence indicates that the major intracellular site of proinsulin processing is the immature secretory granule, which contains the convertases PC1 and PC2 (38) , the acidic environment ofpH 5.5, and the estimated free Ca2+ concentration of 1-10 mM required for optimal activity of the endoproteolytic enzymes (56) (57) (58) (59) (60) (61) (62) . It was previously shown that PC2 is not fully active in the trans-Golgi network and is relatively inefficient in cleaving intact proinsulin (63, 64) . Furthermore, there is experimental evidence for sequential processing mechanisms in which PC1 would act first in the cleavage of proinsulin (64, 65) , followed by the cleavage of des-31,32 proinsulin by PC2. Alteration in this sequence, as shown in the Psammomys, could result in less dficient processing of proinsulin, and hence could lead to hyperproinsulinemia, particularly during overstimulation of biosynthesis as demonstrated by our in situ hybridization experiment. Collectively, these results tend to indicate a dysregulation in the LED, low-energy diet; HED, high-energy diet.
* Figure 6 . Electron micrographs of Unicryl-embedded pancreatic tissues immunolabeled for PCI. (a) In LE diet-fed Psammomys, the PC1 immunoreactivity revealed by the gold particles is associated with the secretory granules, mainly the light-cored ones (lg), whereas (b) in HE diet-fed Psammomys the PC1 immunoreactivity is distributed in the Golgi area (G). The secretory granules (9) are weakly labeled. Original magnification x 25,000. Bar E 0.25 pm. endopeptidase mode of action during prolonged states of glucose stimulation. It has not yet been determined whether the levels of PC1 and PC2 proteins are coordinately regulated in (3-cells, but it has been established that glucose specifically upregulates PCi mRNA translation (67). It is interesting to note that insulin response to glucose load in Psammomys was lower than that of other secretagogues (55) . This may be related to a relative deficiency in conversion enzyme during oventimulation of the secretory pathway arising from hyperglycemia.
The relatively large number of proinsulin-containing granules in (3-cells of hyperglycemic animals, which was twice that found in (3-cells of normal animals, could reflect either a chronic secretory state or a deficiency in processing. Unfortunately, in this study circulating proinsulin was not measured. Our understanding of proinsulin secretion in Psammomys therefore remains incomplete, but reports from NIDDM patients demonstrate elevated ratios of plasma proinsulin to insulin (8, 18, 21) . The cellular content of proinsulin results from a critical balance between synthesis and conversion to insulin. Increased synthesis and/or defective processing would lead to a relative increase of proinsulin. In a number of hyperglycemic models, elevated proinsulin levels have been reported (30,55,68). Our results indicate that impaired proinsulin processing by PC2 andlor by PC1 and PC2 could be the cause.
The present study revealed a significant decrease (15-fold) in the insulin-immunoreactive content of (3-cells in hyperglycemic animals compared with normoglycemic animals. Depletion of mature granules, resulting from an accelerated discharge of proinsulinrich immature granules attributed to the increased secretory demand, would explain this finding. It was a longstanding idea that chronic hyperglycemia depletes the cells of mature granules (9) . Granule release would occur through a very rapid processing pathway that bypasses the maturation-storage stage, leading to high plasma insulin-like immunoreactivity, which is in accordance with values reported in a recent study of the relationship between fed glucose and insulin plasma levels in Psammomys (55) . That study demonstrated an inverted U-shaped curve in which the increase in glucose levels was accompanied by a progressive increase in insulin. However, further increase in glucose levels was associated with a rapid decline in insulin levels. In addition, deficient processing may also result in a tendency towards lysosomal degradation which, in fact, is reflected in these cells by the presence of large insulinreactive, lysosome-like bodies not found in normoglycemic animals. Our results therefore suggest that the decrease of insulin in P-cells could occur through both premature and accelerated granule release and intracellular degradation. 
